Myelodysplastic syndrome after autologous transplantation for lymphoma: the price of progress [editorial]
Author:
- Rm StoneRSRm Stone
Open Access
- 15 June 1994
- journal article
- Published by American Society of Hematology in Blood
- Vol. 83 (12) , 3437-3440
Abstract
P ROGRESS, IT SEEMS, never occurs without unin-tended or unwanted problems. For example,Keywords
This publication has 7 references indexed in Scilit:
- Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.Journal of Clinical Oncology, 1993
- Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas.Journal of Clinical Oncology, 1993
- Importance of bone marrow cytogenetic evaluation before autologous bone marrow transplantation for Hodgkin's disease.Journal of Clinical Oncology, 1991
- Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.Journal of Clinical Oncology, 1990
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaNew England Journal of Medicine, 1989
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACODAnnals of Internal Medicine, 1986